tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI

Brainstorm Cell Therapeutics (BCLI) Stock Investors

489 Followers
Based on 730,199 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BCLI
On average, investors allocate 0.00% of their portfolios to BCLI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BCLI

1.4%
Last 7
Days
3.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BCLI, out of 730,199 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BCLI Investor Activity

No data currently available
Based on the activity of 13,714 investors who made their portfolios public
The table shows changes in BCLI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BCLI Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Assertio Therapeutics
2.67%
-1.40%
-9.27%
86.51M
Healthcare
Coherus Biosciences
2.67%
-1.40%
-8.90%
247.43M
Healthcare
Blink Charging Co
5.05%
-1.40%
-8.07%
237.33M
Industrials
ChargePoint Holdings
3.88%
-1.04%
-7.27%
567.30M
Consumer Cyclical
Marathon Digital Holdings
5.64%
+0.31%
-2.68%
5.49B
Financial
Riot Platforms
5.21%
+3.75%
+2.83%
3.00B
Financial
GE Aerospace
5.54%
+2.08%
+8.36%
177.79B
Industrials
AMC Entertainment
5.50%
-1.08%
-6.88%
893.62M
Communication Services
Merck & Company
4.12%
+0.09%
-1.16%
321.34B
Healthcare
Plug Power
4.91%
-1.17%
-7.06%
1.77B
Industrials
Based on the activity of 730,199 active portfolios
Open your Smart Portfolio

BCLI Investor Analysis

BCLI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.2%
of BCLI holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
BCLI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.4%
of BCLI holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
BCLI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
26.4%
of BCLI holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of BCLI stock investors
See who invests in BCLI according to age group and performance.

FAQ

How many retail Investors hold BCLI?
<0.1% of TipRanks' retail investors hold BCLI in their portfolios.
    What is BCLI Investor Sentiment?
    BCLI’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of BCLI in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of BCLI in the last 7 days.
        What percentage of retail investors changed their holding of BCLI in the last 30 days?
        ▼ 3.8% of TipRanks' retail investors changed their holding of BCLI in the last 30 days.
          What is the average age of retail investors who hold BCLI?
          The average age of BCLI Holders is between 35–55.
            What other stocks have BCLI investors also bought?
            BCLI Investors also bought ASRT, CHRS, BLNK, CHPT, MARA, RIOT, GE, AMC, MRK, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              GERNGeron
              HCAHCA Healthcare
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis